FINWIRES · TerminalLIVE
FINWIRES

BMO Capital Initiates Insmed at Outperform With $192 Price Target

By

Insmed (INSM) has an average rating of buy and mean price target of $196.18, according to analysts polled by FactSet.

What else is happening in Research?